|
| The sample is, after acidification and addition of labeled internal standards, injected and analyzed by using high pressure liquid chromatography and accurate mass mass-selective detection. The surface ofthe peaks in the chromatogram is a measure of the concentration. |
|
|
| Matrices qualified by the Dutch RvA (flexible scope): | Drinking water, Groundwater, Surface water |
| Reporting limit: | 0.01 - 1 μg/l, parameter and matrix dependent |
| Measurement uncertainty: | 70% |
| Sustainability: | 6 days
|
| Sampling bottle: | Glass
, brown
, 100 ml
(fill up to the neck of the bottle)
|
|
| (RL = 0.01 μg/l) | atorvastatin (not accreditated); bisoprolol; clofibric acid; cyclophosphamide; Enalapril; fenofibrate; fenofibrate related compound A; ifosfamide; indomethacin; primidone; tiamulin; sulfadiazine (not accreditated); antipyrine (not accreditated) |
| (RL = 0.02 μg/l) | clofibrate; fluoxetine; furosemide (not accreditated); gemfibrozil; theophylline |
| (RL = 0.05 μg/l) | lincomycine; tramadol |
| (RL = 0.1 μg/l) | chloramphenicol; losartan; sulfaquinoxaline (not accreditated) |
| (RL = 0.2 μg/l) | bezafibrate; paroxetine |
| (RL = 1 μg/l) | pravastatin (not accreditated) |
